Skip to content

Clinical trials

Non-Muscle Invasive Bladder Neoplasms trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-Muscle Invasive Bladder Neoplasms Country / region: Austria Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20182
20211
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting3
Recruiting2
Completed1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
Cepheid1
Ekaterina Laukhtina1
Janssen Research & Development, LLC1
Medical Enterprises Europe B.V.1
University Teaching Hospital Hall in Tirol1
UroGen Pharma Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-Muscle Invasive Bladder Neoplasms7
Neoplasms3
Urinary Bladder Neoplasms3
Carcinoma, Transitional Cell2
Hyperthermia1
Neoplasms by Site1
Neoplastic Cells, Circulating1
Urinary Bladder Diseases1
Urogenital Neoplasms1
Urologic Diseases1

Trials

Showing 26 to 7 of 7. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.